Lexoziff LT Eye Drop contains Levofloxacin 1.5% w/v + Loteprednol Etabonate 0.5% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections with associated inflammation. Its combination ensures rapid infection control and symptom relief.
Levofloxacin acts as a broad-spectrum fluoroquinolone antibiotic, eliminating bacterial pathogens, while Loteprednol provides steroidal anti-inflammatory action, reducing redness, swelling, and discomfort.
From a commercial perspective, Lexoziff LT Eye Drop is a high-demand steroid-antibiotic ophthalmic product, widely prescribed in eye hospitals, specialty clinics, and post-operative care, ensuring consistent demand and repeat prescriptions.
Adding Lexoziff LT Eye Drop to your portfolio strengthens the ophthalmic steroid-antibiotic segment, offering long-term business growth, prescriber confidence, and strong portfolio differentiation for PCD pharma franchise partners.